Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology in Grenada

Grenada: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology was 0.2% in 2024. ▼ Falling

Latest (2024)
0.2%
Change on year
unchanged
World rank
78th
of 215 countries
All-time high
0.4%
in 2015
All-time low
0.2%
in 2018
Years of data
10
2015–2024

Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology in Grenada, 2015–2024

00.10.20.30.42015201920242015: 0.42016: 0.32017: 0.32018: 0.22019: 0.22020: 0.22021: 0.22022: 0.22023: 0.22024: 0.2

Source: United Nations Statistics Division, SDG Global Database.

Analysis

Grenada recorded 0.2% for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in 2024. That is the lowest value across all 10 years on record.

That represents a change of down 50.0% over ten years.

Over the whole period, prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in Grenada peaked at 0.4% in 2015 and was at its lowest, 0.2%, in 2018.

Grenada ranks 78th of 215 countries on this measure, in the middle of the range.

Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology in Grenada, year by year

Annual values for Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%) in Grenada, 2015 to 2024.
Year Value Change
2015 0.4%
2016 0.3% -25.0%
2017 0.3% +0.0%
2018 0.2% -33.3%
2019 0.2% +0.0%
2020 0.2% +0.0%
2021 0.2% +0.0%
2022 0.2% +0.0%
2023 0.2% +0.0%
2024 0.2% +0.0%

Averages by decade

DecadeAverage LowestHighest Years
2010s 0.3% 0.2% 0.4% 5
2020s 0.2% 0.2% 0.2% 5

Countries ranked near Grenada

  1. 78 Anguilla 0.2% compare
  2. 78 Antigua and Barbuda 0.2% compare
  3. 78 Aruba 0.2% compare
  4. 78 Bahamas 0.2% compare
  5. 78 Barbados 0.2% compare
  6. 78 Bonaire, Sint Eustatius and Saba 0.2% compare
  7. 78 British Virgin Islands 0.2% compare
  8. 78 Cayman Islands 0.2% compare
  9. 78 Curaçao 0.2% compare
  10. 78 Dominica 0.2% compare
  11. 78 Fiji 0.2% compare
  12. 78 Guadeloupe 0.2% compare
  13. 78 India 0.2% compare
  14. 78 Jamaica 0.2% compare
  15. 78 Kazakhstan 0.2% compare
  16. 78 Libya 0.2% compare
  17. 78 Maldives 0.2% compare
  18. 78 Martinique 0.2% compare
  19. 78 Montserrat 0.2% compare
  20. 78 Nepal 0.2% compare
  21. 78 North Macedonia 0.2% compare
  22. 78 Pakistan 0.2% compare
  23. 78 Puerto Rico 0.2% compare
  24. 78 Saint Barthélemy 0.2% compare
  25. 78 Saint Kitts and Nevis 0.2% compare
  26. 78 Saint Lucia 0.2% compare
  27. 78 Saint Martin (French part) 0.2% compare
  28. 78 Saint Vincent and the Grenadines 0.2% compare
  29. 78 Sint Maarten 0.2% compare
  30. 78 Suriname 0.2% compare
  31. 78 Tajikistan 0.2% compare
  32. 78 Turks and Caicos Islands 0.2% compare
  33. 78 United States Virgin Islands 0.2% compare

See the full ranking of 236 places →

More development goals data for Grenada

All data for Grenada →

Frequently asked questions

What is prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in Grenada?
Prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in Grenada was 0.2% in 2024, according to United Nations Statistics Division, SDG Global Database.
What is the highest prevalence of hepatitis b surface antigen (hbsag), 2026 methodology recorded in Grenada?
The highest recorded value was 0.4% in 2015.
What is the lowest prevalence of hepatitis b surface antigen (hbsag), 2026 methodology recorded in Grenada?
The lowest recorded value was 0.2% in 2018.
How does Grenada rank for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
Grenada ranks 78th out of 215 countries with data for 2024.
Is prevalence of hepatitis b surface antigen (hbsag), 2026 methodology rising or falling in Grenada?
Over the last ten years it is down 50.0%. The long-run trend across the full record is falling.
Where does this Grenada data come from?
The figures come from United Nations Statistics Division, SDG Global Database, published as part of Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 10 observations, free to reuse under UN SDG Global Database (open, attribution requested).

Share, cite or embed this page

Cite this page

Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology in Grenada. Statizoid, drawing on United Nations Statistics Division, SDG Global Database. Retrieved 22 August 2026, from https://development-goals.statizoid.com/stat/prevalence-of-hepatitis-b-surface-antigen-hbsag-2026-methodology-percent/grenada/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under UN SDG Global Database (open, attribution requested); please keep the attribution.

<a href="https://development-goals.statizoid.com/stat/prevalence-of-hepatitis-b-surface-antigen-hbsag-2026-methodology-percent/grenada/">Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology in Grenada</a> — Statizoid

About this data

Indicator
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%)
Source
United Nations Statistics Division, SDG Global Database
Licence
UN SDG Global Database (open, attribution requested)
Coverage
236 places, 2,360 data points, 2015–2024
Last refreshed